A small pilot trial found that high resistant starch intake reduced systolic blood pressure within the treatment group, though the between-group difference wasn't statistically significant. The findings are preliminary and require larger trials to establish whether this effect is real or incidental.
Resistant starch has accumulated evidence for metabolic benefits, but the mechanisms connecting it to cardiovascular outcomes remain underexplored. Researchers hypothesized that one pathway could involve autonomic nervous system regulation, measurable through heart rate variability (HRV). This 8-week pilot trial tested whether increasing resistant starch intake would shift cardiovascular autonomic tone and reduce blood pressure in women at metabolic risk.
The study enrolled 30 women aged 40 and older with at least two components of metabolic syndrome (elevated blood pressure, triglycerides, fasting glucose, waist circumference, or low HDL cholesterol). Participants were randomly assigned to consume either high-resistant starch or low-resistant starch diets under double-blind conditions. Resistant starch, found in unripe bananas, cooled cooked potatoes, legumes, and some whole grains, resists breakdown in the small intestine and reaches the colon intact, where it feeds beneficial bacteria.
Within the high-resistant starch group, systolic blood pressure fell by a measurable degree (p = 0.037), representing a within-group improvement. However, when comparing the high group directly to the low-resistant starch control group while adjusting for baseline values, the difference did not reach statistical significance. This distinction matters: it suggests the drop observed in the treatment group may reflect natural variation or other unmeasured factors rather than a robust treatment effect. The researchers found no corresponding improvements in body weight, body mass index, or triglyceride levels, which would have strengthened confidence that metabolic changes drove the blood pressure reduction.
Heart rate variability measurements, the study's secondary focus, showed no statistically significant group-level differences. However, an exploratory analysis hinted at a pattern: participants who started with lower autonomic activity appeared to show favorable directional changes in global HRV composite scores in the high-resistant starch group (p = 0.06). This borderline finding sits just outside the conventional significance threshold and remains suggestive rather than conclusive. The authors appropriately frame this as a signal warranting investigation in larger trials, not evidence of efficacy.
This pilot study amounts to an early reconnaissance, not a roadmap. The sample size of 30 participants and lack of statistically significant between-group differences mean the findings are preliminary. If you have metabolic syndrome features and are considering dietary changes, high-fiber diet interventions (which resistant starch is one form of) have broader evidence supporting metabolic health. Resistant starch foods like legumes, cooled potatoes, and unripe bananas are nutritionally dense and inexpensive, so incorporating them into protein-at-every-meal eating patterns carries minimal downside.
The hint that lower-baseline autonomic activity participants may respond better is interesting but unconfirmed. You cannot reliably self-assess your baseline HRV without measurement, and drawing conclusions from a subgroup analysis of 30 people risks false positives. Established blood pressure management approaches including resistance-training, zone-2-cardio, sodium-bicarbonate research (for specific contexts), and potassium adequacy have stronger evidence underpinning them.
| Attribute | Detail |
|---|---|
| Study Type | Randomized, double-blind, controlled trial |
| Sample Size | 30 women, mean age ≥40 years |
| Population | Women with ≥2 metabolic syndrome components |
| Intervention | High-resistant starch diet vs. low-resistant starch control |
| Duration | 8 weeks |
| Primary Outcome | Change in systolic blood pressure (baseline to week 8) |
| Secondary Outcomes | Heart rate variability autonomic parameters |
| Key Finding | Within-group SBP reduction in high-RS group (p=0.037); between-group difference not significant |
| Exploratory Finding | Favorable HRV directional pattern in lower baseline autonomic activity subgroup (p=0.06) |
| Journal | The Journal of International Medical Research |
| PubMed ID | 42754828 |
| Evidence Tier | B tier (small RCT, preliminary signals, larger confirmation needed) |
Harmon, K. A., et al. (2024). Effects of resistant starch on blood pressure and autonomic function in women with the risk of metabolic syndrome: A randomized double-blind pilot study. The Journal of International Medical Research. https://pubmed.ncbi.nlm.nih.gov/42754828/
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.